FindTrial
Sign In

Comparing health outcomes of a hormone releasing intra uterine device versus surgical removal of uterus for treating abnormal uterine bleeding.

Clinical outcomes with levonorgestrel releasing intrauterine system versus laparoscopic hysterectomy in AUB - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/103456
Enrollment
88
Registered
2026-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

KASTURBA MEDICAL COLLEGE MANIPAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: AUB-A (Adenomyosis),P (POLYP), AUB-L (Leiomyoma less than , equal to 16 weeks size)

Exclusion criteria

Exclusion criteria: AUB-L (leiomyoma more than 16 weeks size), AUB-C (Coagulopathy), AUB-I (Iatrogenic), AUB-N (Neoplasia), AV malformations

Design outcomes

Primary

MeasureTime frame
Efficacy, quality of life, sexual health, emotional health, physical and general health, and psychological healthTimepoint: before procedure, 6 months and 1 year after procedure—

Secondary

MeasureTime frame
Improvement in haemoglobin levels to asess correction of anemia, changes in endometrial thickness (in the LNG-IUS group), patient satisfaction, changes in menstrual patterns, duration of hospital stay, time taken to resume normal activitiesTimepoint: before procedure, 6 months and 1 year post procedure—

Countries

India

Contacts

Public ContactJyothi Shetty

Kasturba Medical College, Manipal

jyothi.shetty@manipal.edu

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026